Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

AC Immune (ACIU) EPS (Basic) (2016 - 2025)

AC Immune has reported EPS (Basic) over the past 10 years, most recently at -$0.14 for Q4 2025.

  • Quarterly EPS (Basic) fell 1891.04% to -$0.14 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$0.17 through Dec 2025, down 609.79% year-over-year, with the annual reading at -$0.88 for FY2025, 50.44% down from the prior year.
  • EPS (Basic) was -$0.14 for Q4 2025 at AC Immune, down from -$0.01 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $0.0 in Q3 2024 and troughed at -$0.24 in Q4 2021.
  • The 5-year median for EPS (Basic) is -$0.01 (2021), against an average of -$0.04.
  • Year-over-year, EPS (Basic) surged 129.54% in 2024 and then crashed 1891.04% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at -$0.24 in 2021, then rose by 5.4% to -$0.22 in 2022, then skyrocketed by 75.04% to -$0.06 in 2023, then surged by 87.33% to -$0.01 in 2024, then tumbled by 1891.04% to -$0.14 in 2025.
  • Per Business Quant, the three most recent readings for ACIU's EPS (Basic) are -$0.14 (Q4 2025), -$0.01 (Q3 2025), and -$0.01 (Q2 2025).